Visit
VJHemOnc is excited to present the latest developments in the role of chemotherapy across lymphomas
VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…
VJHemOnc is excited to bring you the latest research updates in lymphoid malignancies from the EHA 2022 Congress, which took…
VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!
Updated results from the ECHELON-1 study (NCT01712490) suggest the combination of brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine (A+AVD) may…
Twenty-five years ago, almost to the day, there was a paradigm shift in the classification of lymphoma.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter